Connect Biopharma HldgsCNTB
13F holders, Q2 2026 (June 30)1holders
1new positions
1sold out
$2.38avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Connect Biopharma Hldgs Ltd. (CNTB) in their 13F filings, unchanged from Q1 2026. 1 opened new positions and 1 sold out. The largest holder was Quadrature Capital Ltd ($101K).
- Company
- Connect Biopharma Hldgs Ltd.
- CUSIP
- 207523101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $101K |
| Exits | 1 | $3K |
All 13F filers, Q1 2026 → Q2 2026: 42,303 shares bought and 1,247 shares sold, net +41,056 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Quadrature Capital Ltd | 0.00% | New | 42,303 | $101K |
"% of holder's portfolio" is CNTB's weight in each manager's 13F, not the share of Connect Biopharma Hldgs Ltd. the manager owns.